This timeline covers the key milestones and breakthroughs in CRISPR and synthetic biology from the early 2000s to the present, highlighting the discovery of CRISPR-Cas9, its application in gene editing, and the expansion of synthetic biology into medicine, agriculture, and biotechnology.
Scientists identify CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) loci in bacterial genomes, noting their association with Cas genes. This discovery sets the stage for understanding bacterial adaptive immunity. #CRISPR #genetics #microbiology
Three independent research groups show that CRISPR spacers match sequences from bacteriophages and plasmids, suggesting CRISPR functions as an adaptive immune system in bacteria. #CRISPR #immunity #bacteriophage
Barrangou et al. demonstrate that Streptococcus thermophilus acquires resistance against bacteriophages by integrating new spacers into CRISPR loci, providing the first experimental evidence of CRISPR-mediated adaptive immunity. #CRISPR #immunity #probiotics
Brouns et al. show that CRISPR-associated (Cas) proteins process CRISPR RNA (crRNA) to guide interference against invading nucleic acids in E. coli, elucidating the molecular mechanism. #CRISPR #RNA #interference
Garneau et al. demonstrate that Cas9 is the nuclease responsible for cleaving target DNA in Streptococcus thermophilus, showing that Cas9 creates double-strand breaks at specific sites. #CRISPR #Cas9 #DNA
Makarova et al. classify CRISPR-Cas systems into three types, with Type II requiring a single Cas9 protein for interference, simplifying the system for potential applications. #CRISPR #classification #Cas9
Jinek et al. (Doudna/Charpentier) show that Cas9 can be programmed with a single guide RNA (sgRNA) to cleave specific DNA sequences in vitro, revolutionizing gene editing. #CRISPR #Cas9 #geneediting
Cong et al. (Zhang) and Mali et al. (Church) independently demonstrate CRISPR-Cas9-mediated genome editing in human cells, opening the door for therapeutic applications. #CRISPR #humangenome #geneediting
Researchers show that CRISPR-Cas9 can edit multiple genes simultaneously in human cells, enabling complex genetic modifications. #CRISPR #multiplex #genetics
Nishimasu et al. (Nureki) determine the crystal structure of Cas9 bound to guide RNA and target DNA, providing insights into its mechanism and enabling rational engineering. #CRISPR #Cas9 #structure
Successful application of CRISPR-Cas9 in zebrafish and mice demonstrates its utility in creating animal models for human diseases. #CRISPR #animalmodels #zebrafish
Chinese scientists report the first (controversial) attempt to edit non-viable human embryos using CRISPR-Cas9, sparking global ethical debates. #CRISPR #ethics #humanembryos
Zetsche et al. (Zhang) characterize Cpf1 (Cas12a), a CRISPR nuclease with distinct properties, including staggered cuts and simpler guide RNA requirements. #CRISPR #Cas12a #Cpf1
The US National Institutes of Health approves the first clinical trial using CRISPR-Cas9 to engineer T cells for cancer immunotherapy. #CRISPR #clinicaltrial #immunotherapy
Gootenberg et al. (Zhang) develop SHERLOCK, a CRISPR-based diagnostic platform for rapid, sensitive detection of nucleic acids, including viruses. #CRISPR #diagnostics #SHERLOCK
US researchers successfully correct a heterozygous mutation in human embryos using CRISPR, demonstrating potential for germline editing. #CRISPR #germline #genetherapy
Researchers develop CRISPR-based gene drives in mosquitoes to spread anti-malarial genes, raising hopes for disease control but also ecological concerns. #CRISPR #genedrive #malaria
The US Department of Agriculture approves CRISPR-edited mushrooms and soybeans, exempting them from GMO regulations. #CRISPR #agriculture #GMO
Chinese scientist He Jiankui claims to have created the first CRISPR-edited human babies, sparking international outrage and calls for regulation. #CRISPR #ethics #humanexperiment
Researchers adapt CRISPR diagnostics (SHERLOCK, DETECTR) for rapid detection of SARS-CoV-2, aiding pandemic response. #CRISPR #COVID19 #diagnostics
Vertex and CRISPR Therapeutics begin clinical trials of CTX001, a CRISPR-edited cell therapy for sickle cell disease and beta-thalassemia. #CRISPR #genetherapy #sicklecell
Emmanuelle Charpentier and Jennifer Doudna awarded the Nobel Prize in Chemistry for developing the CRISPR-Cas9 gene-editing tool. #CRISPR #NobelPrize #Doudna
The FDA approves exagamglogene autotemcel (Casgevy) for sickle cell disease, the first CRISPR-based therapy approved in the US. #CRISPR #FDA #sicklecell
Anzalone et al. (Liu) develop prime editing, a CRISPR-based method that enables precise gene editing without double-strand breaks. #CRISPR #primeediting #genomeediting
Clinical trials show CRISPR-edited T cells (e.g., NY-ESO-1) are safe and effective against certain cancers, advancing immunotherapy. #CRISPR #cancer #immunotherapy
Researchers use CRISPR to excise HIV proviral DNA from infected cells in animal models, moving toward a potential cure. #CRISPR #HIV #cure
Scientists create CRISPR-edited pigs with reduced immunogenicity, bringing xenotransplantation closer to clinical reality. #CRISPR #xenotransplantation #pigs
Casgevy receives approval for beta-thalassemia in the UK, expanding access to CRISPR-based treatments. #CRISPR #thalassemia #genetherapy
Researchers develop portable CRISPR biosensors to detect pollutants and pathogens in water and soil, expanding applications beyond medicine. #CRISPR #biosensor #environment
Field trials of CRISPR-edited wheat and rice show enhanced resistance to fungal diseases, promising reduced pesticide use. #CRISPR #agriculture #crops
Clinical trial results show that CRISPR injected directly into the eye restores vision in patients with Leber congenital amaurosis. #CRISPR #blindness #genetherapy
First clinical trial of CRISPR-based epigenome editing aims to silence disease-causing genes without altering DNA sequence. #CRISPR #epigenetics #genetherapy
Researchers create a synthetic minimal bacterial genome with only essential genes, advancing understanding of life's basics. #syntheticbiology #genome #minimal
Clinical trials begin using CRISPR to engineer T cells that target and suppress autoimmune responses in lupus and multiple sclerosis. #CRISPR #autoimmune #Tcells
The Synthetic Yeast Genome Project (Sc2.0) completes the first fully synthetic eukaryotic chromosome, enabling custom-designed organisms. #syntheticbiology #yeast #chromosome
A new CRISPR system (Cas13) is used to edit RNA in patients with Huntington's disease, offering a reversible therapeutic approach. #CRISPR #RNAediting #Huntingtons
International commission releases ethical guidelines for heritable human genome editing, balancing innovation with safety. #CRISPR #ethics #germline
Engineered bacteria with CRISPR systems are used to treat gut diseases by targeting pathogenic microbes in the microbiome. #CRISPR #microbiome #probiotics
Scientists create synthetic chloroplasts that fix CO2 more efficiently than natural ones, promising carbon capture and biofuel production. #syntheticbiology #photosynthesis #climate
Field trials in Africa show CRISPR gene drives reduce mosquito populations by 90%, raising hopes for malaria elimination. #CRISPR #malaria #genedrive
Clinical trial results show CRISPR restores dystrophin expression in muscle cells, improving function in DMD patients. #CRISPR #musculardystrophy #genetherapy
Engineered cells with synthetic gene circuits are used to deliver therapeutic proteins directly to tumors, enhancing precision medicine. #syntheticbiology #drugdelivery #cancer
Portable CRISPR devices are deployed globally for rapid detection of emerging pathogens, forming a global surveillance network. #CRISPR #pandemic #diagnostics
CRISPR-edited pigs resistant to African swine fever are approved for farming, reducing economic losses. #CRISPR #livestock #disease
Engineered bacteria produce self-healing concrete and polymers, reducing maintenance costs and environmental impact. #syntheticbiology #materials #selfhealing
CRISPR is used to reduce amyloid-beta production in the brain, showing cognitive improvement in early-stage Alzheimer's patients. #CRISPR #Alzheimers #genetherapy
Engineered algae strains produce high yields of biodiesel, becoming commercially viable and reducing reliance on fossil fuels. #syntheticbiology #biofuel #algae
Researchers use CRISPR to activate telomerase and reverse epigenetic aging in mice, extending lifespan by 30%. #CRISPR #aging #longevity
UN member states agree on international regulations for CRISPR applications in humans, agriculture, and the environment. #CRISPR #regulation #global
Scientists create a fully synthetic eukaryotic cell with a minimal genome, capable of division and metabolism, marking a new era in synthetic biology. #syntheticbiology #artificialcell #eukaryote